Galactosyltransferase Engineering Service
Diversity of Galactosyltransferase (GalT) Species
GalT is a catalytic enzyme belonging to the Glucosyltransferases (GTs) family. Its main function is to transfer active galactose residues from nucleoside diphosphate molecules to glycosyl acceptor molecules. Due to the formation of the different disaccharide bonds, it can be classified into β-1,3-galactosyltransferase (B3galts), β-1,4-galactosyltransferase (B4galts), and other types.
In prokaryotes, GalTs are involved in the synthesis of extracellular polysaccharides. In eukaryotes, GalTs are involved in the formation of several types of glycoconjugates and the biosynthesis of lactose. GalTs are an important subgroup of GTs. They play many important roles in the fundamental processes of life and are also involved in the development of many diseases. Therefore, GalTs would be potential drug targets.
At CD BioGlyco, we understand that unlocking the full potential of glycobiology hinges on the capacity to accurately regulate and modify glycosylation pathways. Our GalT engineering service offers a refined platform for crafting, building, and enhancing these crucial enzymes, empowering clients to gain precise command over glycan structure and functionality. Whether your goal is to boost the catalytic performance of an existing enzyme, adjust its substrate preferences for innovative glycan synthesis, or integrate a new glycosylation pathway into host cells, our service is customized to meet your project’s distinct needs.
Key Technologies
At the core of our methodology lies the application of cutting-edge gene editing tools to precisely alter host cell genomes. This enables us to eliminate, overproduce specific GalT genes, and introduce new enzyme variants. Our proficiency in developing highly targeted guide RNAs and refining transfection procedures guarantees efficient gene editing with reduced off-target impacts.
Advancing Glycoscience with Engineered GalT
CD BioGlyco continues to improve the technology of gene editing. Throughout the experiments, we are equipped with professional project managers to closely follow the progress of the experiments. We are experienced in genetic research on animals, microorganisms, and plants. Our services include the effects of GalT gene modification on cancer cells, brain damage, phycocyanin, prokaryotic extracellular polysaccharides, etc. We also provide GalT heterologous expression service. We provide gene modification services for the following genes.
- B3galts gene modification service
B3galts is an important member of the family of GalT. Its main function is to transfer galactose from UDP-galactose or UDP-N-acetylglucosamine to N-acetylglucosamine or N-acetylgalactose. There is a total of 7 members in the B3galTs family, including B3galt1, B3galt2, B3galt3, B3galt4, B3galt5, B3galt6, and B3galt7. We test the effect of B3galts gene deletion using detecting Knockout heterozygotes. - B4galtsgene modification service
B4galts transfer galactose to oligosaccharides. There are seven members of the B4galts family. The study surfaces its great influence on the long-term memory learning ability in the hippocampal region of the brain. We provide B4galts knockout services to study its effects on the blood-brain barrier, neurons, and others in the hippocampal region of the animal brain. - UDP-galactose: anthocyanidin 3-O-galactosyltransferase (UA3GalT) gene modification service
UA3GalT is a key enzyme in anthocyanin biosynthesis. We provide gene modification services such as UA3GalT cloning and Overexpression. - Alpha-1,3-galactosyltransferase (α1,3-GT) gene modification service
α1,3-GT catalyzes the formation of xenoantigens recognized by natural antibodies. Reducing or even avoiding the production of donor Galα(1,3)Gal by inhibiting the expression of α1,3-GT is a practical way to control hyperacute rejection of xenografts. We provide α1,3-GT knockdown service. - Other GalT gene modification services
In prokaryotic extracellular polysaccharide synthesis, GalT catalyzes the key enzyme in the transfer of sugar fractions from activated donor molecules to specific lipophilic acceptors. In addition to animals and plants, we study the effects of GalT gene modifications in prokaryotes.
Fig. 1 One-stop GalT gene modification service. (CD BioGlyco)
Workflow
Published Data
Paper Title: Repair of bone defects in rhesus monkeys with α1,3-galactosyltransferase-knockout pig cancellous bone
Technology: Glycogene Knockout
Journal: Frontiers in Bioengineering and Biotechnology
IF: 5.7
Published: 2022
Results: Knockdown of α1,3-GT reduced the heterologous immunogenicity of GTKO porcine bone compared with the control group. The expressions of IL-2 and INF-γ were reduced in the GTKO group. The results showed that the knockdown of α1,3-GT reduced immune rejection.
Fig.2 Evaluation of immune rejection in xenotransplantation. (Wang, et al., 2022)
Applications
- GalT is found to play an important role in pathological processes such as cerebral ischaemic injury. However, the mechanism is not clear. The gene editing of GalT has a crucial role in the development of the disease.
- GalT may be involved in the synthesis of pigments such as anthocyanin in plants. Overexpression of GalT validates its biological function in plants.
- GalT plays an important role in various biological activities such as embryonic and nervous system development, signal transduction, etc. The technologies for GalT gene editing are used to study the biological function of glycosylation.
Highlights
- We have a well-established project management process and strict quality control to ensure that the project is completed efficiently and on time.
- We have a complete range of gene editing vectors for knockout, insertion, inhibition, activation, and other purposes.
- With high gene-cutting efficiency, high specificity, and very low off-target rate, we precisely edit the genome, which greatly shortens the experimental cycle.
Frequently Asked Questions
CD BioGlyco has abundant animal and other models for basic research or drug discovery. We also provide experimental progress and after-sales service on a stage-by-stage basis. If you need customized gene modification services, please feel free to contact us for specific information.
Associated Services
To help you achieve your complete project goals, CD BioGlyco offers a range of complementary services that are seamlessly integrated with our GalT engineering service.
- Glycan Profiling: We provide comprehensive qualitative and quantitative analysis of glycans from your engineered cell lines or final products. This service is a perfect complement to validate the success of your GalT engineering project.
- Recombinant Glycoprotein Expression: For clients who need to produce large quantities of glycoproteins with specific glycosylation patterns, our expression services take your engineered cell line and scale up production.
- Custom Glycoconjugate Synthesis: Beyond enzyme engineering, we chemically or enzymatically synthesize custom glycoconjugates for your research needs.
Reference
- Chang, L.; et al. Effective genome editing and identification of a regiospecific gallic acid 4-O-glycosyltransferase in pomegranate (Punica granatum L.). Horticulture research. 2019, 6. (Open Access)
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




